ARCHIVES

NCI blocked groups from phase III Iressa studies.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

Varmus Discusses Grant Policy, Changes in Congress and Ebola

December 12, 2014

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

Commission Urges Bypass Funding for Breast Cancer

November 5, 1993

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006